June 10, 2026 Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment
June 10, 2026 Patton Awarded Subcontract to Develop Source-Secure Fiber Optic Modules for U.S. Defense Applications
